Related Experiment Video
Updated: Jan 26, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Transcriptional repression by androgen receptor: roles in castration-resistant prostate cancer
Galina Gritsina1, Wei-Qiang Gao2, Jindan Yu1,3,4
1Division of Hematology/Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Abstract:
Androgen receptor (AR), a hormonal transcription factor, plays important roles during prostate cancer progression and is a key target for therapeutic interventions. While androgen-deprivation therapies are initially successful in regressing prostate tumors, the disease ultimately comes back as castration-resistant prostate cancer (CRPC) or at the late stage as neuroendocrine prostate cancer (NEPC). CRPC remains largely dependent on hyperactive AR signaling in the milieu of low androgen, while NEPC is negative of AR expression but positive of many AR-repressed genes. Recent technological advances in genome-wide analysis of transcription factor binding sites have revealed an unprecedented set of AR target genes. In addition to its well-known function in activating gene expression, AR is increasingly known to also act as a transcriptional repressor. Here, we review the molecular mechanisms by which AR represses gene expression. We also summarize AR-repressed genes that are aberrantly upregulated in CRPC and NEPC and represent promising targets for therapeutic intervention.
Insights
Androgen receptor (AR) represses gene expression, a role crucial in prostate cancer progression. Understanding AR
Area of Science:
- Oncology and Molecular Biology
Background:
- Androgen receptor (AR) is a key factor in prostate cancer progression and a therapeutic target.
- Androgen-deprivation therapies can lead to castration-resistant prostate cancer (CRPC) and neuroendocrine prostate cancer (NEPC).
- CRPC relies on AR signaling, while NEPC involves AR-repressed genes.
Purpose of the Study:
- To review the molecular mechanisms of AR-mediated gene repression.
- To summarize AR-repressed genes upregulated in CRPC and NEPC.
- To identify potential therapeutic targets based on AR's repressive function.
Main Methods:
- Review of recent literature on AR function and genome-wide analyses.
- Analysis of AR's role as a transcriptional repressor.
- Compilation of data on AR-repressed genes in prostate cancer subtypes.
Main Results:
- AR functions not only as an activator but also as a transcriptional repressor.
- Genome-wide studies reveal numerous AR target genes.
- Specific AR-repressed genes are aberrantly upregulated in CRPC and NEPC.
Conclusions:
- AR's repressive function is critical in prostate cancer development and progression.
- AR-repressed genes represent promising therapeutic targets for CRPC and NEPC.
- Further research into AR's repressive mechanisms can guide novel treatment strategies.
Related Concept Videos
Internal Receptors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Treatment Resistant Cancers
Repressed Memory
Transcription
Transcription is the process of synthesizing RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in the proper synthesis of messenger RNA (mRNA). Regulation of transcription is responsible for the differentiation of all the different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds...
Repressible Operon: trp Operon

